HHMI

The prototype system uses viral genome data to act as a framework for real-time molecular epidemiology and evolutionary analysis of emerging epidemics.

The Wellcome Trust, the Max Planck Society, and the Howard Hughes Medical Institute will continue to support the open-access journal eLife, according to Nature News.

For Success

Erin O'Shea, the next HHMI president, plans to enable women and under-represented groups to be successful, Nature News reports.

The funding, which is being provided by the Howard Hughes Medical Institute, will also be used to expand the lab's outreach efforts to underrepresented student groups.

Back to the Bench

Robert Tjian is stepping down at the end of next year as the head of the Howard Hughes Medical Institute.

Three philanthropies have teamed up on a new program to support early career researchers in the biomedical sciences.

Illumina announced that Robert Epstein has joined its board of directors. Epstein formerly was chief R&D officer and president of Medco-UBC, and he was Medco’s chief medical officer for 13 years.

Paired Ends

Premium

Rob Martienssen, Joseph Ecker, David Haussler, Todd Dickinson, Xing Yang

The value of HHMI's endowment fund rose to $14.8 billion from nearly $14 billion in the previous fiscal year ended Aug. 31, 2009, as financial markets rebounded with the economy.

The instruments will be among the first 20 or so commercial sequencers shipped by PacBio and are expected to be delivered after mid-November. HHMI plans to select the host institutions in August.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.